Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (361-370 of 647) with videos related to

Pageof 65
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 3, 2025
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™)Ruth Tal-Singer, James D Chalmers, Paul W Jones, et al.
Thorax|August 29, 2020
Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort studyBenjamin J Parcell, Kathryn Brechin, Sarah Allstaff, et al.
Respiratory Medicine|March 6, 2010
Right ventricular dilation on CT pulmonary angiogram independently predicts mortality in pulmonary embolismAran Singanayagam, James D Chalmers, Caroline Scally, et al.
The European Respiratory Journal|July 21, 2022
COVID-19 follow-up programs across Europe: an ERS END-COVID CRC surveyClaudia Valenzuela, Mattia Nigro, James D Chalmers, et al.
Gastroenterology|April 30, 1999
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialG D'haens, S Van Deventer, R Van Hogezand, et al.
The Lancet. Respiratory Medicine|January 20, 2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trialsCharles S Haworth, Diana Bilton, James D Chalmers, et al.
The European Respiratory Journal|December 1, 2018
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research CollaborationStefano Aliberti, Eva Polverino, James D Chalmers, et al.
Annals of the American Thoracic Society|November 14, 2023
Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims StudyAnnika Åstrand, Steven J Kiddle, Rohith Siva Ganesh Mudedla, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Safety and Antimicrobial Efficacy of CSL787, A Novel Nebulized IgG Therapy, in Patients with Bronchiectasis: Results from a Randomized Phase 1 TrialDamian G Downey, Ilka Schulze, Andreas Eich, et al.
Thorax|April 19, 2020
Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasisLuis Carreto, Meghan Morrison, Jackie Donovan, et al.
Pageof 65

Showing results (361-370 of 647) with videos related to

Sort By:
Pageof 65
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|June 3, 2025
The Chronic Airways Assessment Test (CAAT™): Evolution From the COPD Assessment Test (CAT™)Ruth Tal-Singer, James D Chalmers, Paul W Jones, et al.
Thorax|August 29, 2020
Drive-through testing for SARS-CoV-2 in symptomatic health and social care workers and household members: an observational cohort studyBenjamin J Parcell, Kathryn Brechin, Sarah Allstaff, et al.
Respiratory Medicine|March 6, 2010
Right ventricular dilation on CT pulmonary angiogram independently predicts mortality in pulmonary embolismAran Singanayagam, James D Chalmers, Caroline Scally, et al.
The European Respiratory Journal|July 21, 2022
COVID-19 follow-up programs across Europe: an ERS END-COVID CRC surveyClaudia Valenzuela, Mattia Nigro, James D Chalmers, et al.
Gastroenterology|April 30, 1999
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trialG D'haens, S Van Deventer, R Van Hogezand, et al.
The Lancet. Respiratory Medicine|January 20, 2019
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trialsCharles S Haworth, Diana Bilton, James D Chalmers, et al.
The European Respiratory Journal|December 1, 2018
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research CollaborationStefano Aliberti, Eva Polverino, James D Chalmers, et al.
Annals of the American Thoracic Society|November 14, 2023
Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims StudyAnnika Åstrand, Steven J Kiddle, Rohith Siva Ganesh Mudedla, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Safety and Antimicrobial Efficacy of CSL787, A Novel Nebulized IgG Therapy, in Patients with Bronchiectasis: Results from a Randomized Phase 1 TrialDamian G Downey, Ilka Schulze, Andreas Eich, et al.
Thorax|April 19, 2020
Utility of routine screening for alpha-1 antitrypsin deficiency in patients with bronchiectasisLuis Carreto, Meghan Morrison, Jackie Donovan, et al.
Pageof 65